Kreimer, Anat
Ashuach, Tal
Inoue, Fumitaka http://orcid.org/0000-0003-0657-434X
Khodaverdian, Alex
Deng, Chengyu
Yosef, Nir http://orcid.org/0000-0001-9004-1225
Ahituv, Nadav http://orcid.org/0000-0002-7434-8144
Article History
Received: 8 March 2021
Accepted: 4 February 2022
First Online: 21 March 2022
Competing interests
: N.A. is an equity holder of and a scientific advisor for Encoded Therapeutics, a gene regulation therapeutics company and is a co-founder of Regel Therapeutics. N.A. is also a co-inventor on related patent (Publication number WO/2018/148256) and patent (US Patent US2018017186) submitted by the University of California, San Francisco, that covers gene therapy for haploinsufficiency. N.Y. is an advisor for and/or has equity in Cellarity, Celsius Therapeutics, and Rheos Medicines. T.A. is an employee of Patch Biosciences. The remaining authors declare no competing interests.